News Image

Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations

Provided By GlobeNewswire

Last update: Oct 28, 2025

Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications

Read more at globenewswire.com

PALISADE BIO INC

NASDAQ:PALI (12/19/2025, 8:09:08 PM)

After market: 1.8201 -0.01 (-0.54%)

1.83

+0.16 (+9.58%)



Find more stocks in the Stock Screener

Follow ChartMill for more